<DOC>
	<DOCNO>NCT02806453</DOCNO>
	<brief_summary>A randomize control cross-over trial full-term infant affect symptom suggestive GER , evaluate validated questionnaire ( Infant Gastroesophageal Reflux Questionnaire Revised ) . The parent enrol infant reassure benign nature condition advise apply lifestyle change one week . Than , patient randomize one two sequence treatment group . ( group A : Mg alginate/thickened formula ; group B : thicken formula/Mg alginate ) two week . Evaluation symptom score perform day 0 , day 7 , day 21 day 35 .</brief_summary>
	<brief_title>Effect Magnesium Alginate Gastroesophageal Reflux Infants .</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Alginic acid</mesh_term>
	<criteria>fullterm age 3 12 month , affect symptom suggestive GER . infant regurgitation define accord Rome IV criterion inform consent Evidence chronic disease , hepatic , renal , cardiac disease , metabolic central nervous system disease , use acid suppressor treatment ( H2receptor antagonists proton pump inhibitor [ PPIs ] ) , thicken formula , history prematurity atopy</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>1 Year</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>